Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday

  • 📰 CNBC
  • ⏱ Reading Time:
  • 63 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 72%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland Sc

In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.U.S. drugmaker Pfizer and German biotech BioNTech said they began their late-stage human trial for a potential coronavirus vaccine on Monday as pharmaceutical companies race to win regulatory approval before the end of the year.

The trial will include up to 30,000 participants between the ages of 18 and 85 across 120 sites globally, the companies announced. If successful, they expect to submit it for final regulatory review as early as October. The decision to start the trial reflects "our primary goal to bring a well-tolerated, highly effective vaccine to the market as quickly as possible, while we will continue to evaluate our other vaccine candidates as part of a differentiated COVID-19 vaccine portfolio," BioNTech CEO Ugur Sahin said in a release. "Many steps have been taken towards this important milestone and we would like to thank all those involved for their extraordinary commitment.

The companies' experimental vaccine, uses messenger ribonucleic acid, or mRNA molecules, to provoke an immune response to fight the virus. Scientists hope mRNA, which relays genetic instructions from DNA, can be used to train the immune system to recognize and destroy the virus. Earlier this month, the companies said one of its four coronavirus vaccine candidates produced neutralizing antibodies, which researchers believe is necessary to build immunity to the virus, in all participants who received two of the 10 or 30 microgram doses.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

More pumping the the stock market

Pfizer cured my hemophilia B with one injection in February. Another Phase 3 trial. Very grateful.

Bullish!!!!!!

Pure... magic. Development, trials and legal beaurocracy in just months. 100% PharMaffia.

CNBC Pandemic Propaganda Puppets. Time for you to step up the coverage of front line doctors and their first hand experience at treating CV19 patients the last 4 1/2 months. Have you Puppets ever interviewed doctors on the front lines? When was lady time DrG treated a patient?

ALL EVERYBODY TALKS ABOUT ARE VACCINES. IT'S GOING TO BE AWHILE UNTIL WE HAVE ONE. WE NEED TO CONCENTRATE ALL OUR EFFORTS INTO FLATTEN THE CURVE SO WE CAN ALL GET BACK TO NORMAL. WE NEED AND WANT OUR FREEDOM. OUR KIDS NEED THEIR FREEDOM.

CNBC Pandemic Propaganda Puppets. Did you see the White Coat Summit today, composed of 45 front line doctors around the USA, exposing the myth that HCQ doesn’t work? One physician 350 patients treated, no deaths.HCQ in use for 65 years, safe. Puppets, Interview frontline doctors.

🤐🤐🤐

Hard pass. Not interested in ingesting anything from “those people”

Lotta hype lotta spark. Who's going first?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna's COVID-19 vaccine candidate moves into late-stage trialModerna Inc said on Monday it has started a U.S. government-backed late-stage trial for its COVID-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed anti-coronavirus program. RUSH FOR GRUMP No grazie 🖖 Rinse. Repeat.
Source: Reuters - 🏆 2. / 97 Read more »

Moderna’s Coronavirus Vaccine Begins Final-Stage TestingModerna’s pivotal vaccine trial will evaluate, in 30,000 subjects across the U.S., whether two doses protects against symptomatic Covid-19 Mask Mafia Karens get to go first My family and I refuse to partake in any vaccine. We’d rather they come up with a cure real soon.
Source: WSJ - 🏆 98. / 63 Read more »

First Phase 3 clinical trial of a coronavirus vaccine in the United States beginsThe investigational vaccine was developed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial is to be conducted at nearly 100 US research sites, according to Moderna. First 30,000 volunteers two weeks after taking the vaccine. Not everyone is gonna want the vaccine because all these anti-vaccers and conspiracy theorists. I'm sure it will be ready by election day.
Source: cnnbrk - 🏆 393. / 55 Read more »